These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Byington CL; Samore MH; Stoddard GJ; Barlow S; Daly J; Korgenski K; Firth S; Glover D; Jensen J; Mason EO; Shutt CK; Pavia AT Clin Infect Dis; 2005 Jul; 41(1):21-9. PubMed ID: 15937758 [TBL] [Abstract][Full Text] [Related]
3. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Byington CL; Korgenski K; Daly J; Ampofo K; Pavia A; Mason EO Pediatr Infect Dis J; 2006 Mar; 25(3):250-4. PubMed ID: 16511389 [TBL] [Abstract][Full Text] [Related]
4. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859 [TBL] [Abstract][Full Text] [Related]
5. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)]. Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998 [TBL] [Abstract][Full Text] [Related]
6. Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain. Guevara M; Barricarte A; Gil-Setas A; García-Irure JJ; Beristain X; Torroba L; Petit A; Polo Vigas ME; Aguinaga A; Castilla J Clin Microbiol Infect; 2009 Nov; 15(11):1013-9. PubMed ID: 19673968 [TBL] [Abstract][Full Text] [Related]
7. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Kellner JD; Vanderkooi OG; MacDonald J; Church DL; Tyrrell GJ; Scheifele DW Clin Infect Dis; 2009 Jul; 49(2):205-12. PubMed ID: 19508165 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357 [TBL] [Abstract][Full Text] [Related]
9. Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era. Kendall BA; Dascomb KK; Mehta RR; Mason EO; Ampofo K; Pombo DJ; Pavia AT; Byington CL Vaccine; 2011 Nov; 29(49):9123-6. PubMed ID: 22001280 [TBL] [Abstract][Full Text] [Related]
10. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease. Weatherholtz R; Millar EV; Moulton LH; Reid R; Rudolph K; Santosham M; O'Brien KL Clin Infect Dis; 2010 May; 50(9):1238-46. PubMed ID: 20367225 [TBL] [Abstract][Full Text] [Related]
12. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes. Lehmann D; Willis J; Moore HC; Giele C; Murphy D; Keil AD; Harrison C; Bayley K; Watson M; Richmond P Clin Infect Dis; 2010 Jun; 50(11):1477-86. PubMed ID: 20420501 [TBL] [Abstract][Full Text] [Related]
13. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine. Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369 [TBL] [Abstract][Full Text] [Related]
14. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Isaacman DJ; McIntosh ED; Reinert RR Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359 [TBL] [Abstract][Full Text] [Related]
15. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance. Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605 [TBL] [Abstract][Full Text] [Related]